The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic kidney cancer. The late breaking results are presented at ESMO 2020.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "New first-line treatment option for metastatic kidney cancer"
Post a Comment